Form 4: Astrana Health Director Exercises Options Under 10b5-1 Plan

Astrana Health, Inc. Director Mitchell W. Kitayama acquired 12,000 shares of common stock through a pre-planned option exercise, increasing his direct beneficial ownership.

Summary

• Mitchell W. Kitayama, a Director of Astrana Health, Inc., acquired 12,000 shares of common stock on November 7, 2025.
• The acquisition was made through the exercise of stock options at a price of $18.2 per share.
• This transaction was conducted pursuant to a Rule 10b5-1 pre-planned contract, instruction, or written plan.
• Following the transaction, Mr. Kitayama beneficially owns 27,846 shares of Astrana Health common stock.
• The reported beneficial ownership includes 6,449 shares of restricted stock, which are scheduled to vest on the earlier of June 11, 2026, or the Issuer's 2026 annual meeting of stockholders.
• The exercised stock options were fully vested and exercisable, with an expiration date of November 11, 2025.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director and subsequent increase in direct ownership generally indicates confidence in the company, though it is a routine compensation event executed under a pre-planned 10b5-1 program.

Positives

• A director increasing their direct ownership in the company, even through option exercise, can signal confidence in the company's future prospects and alignment with shareholder interests.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view the director's increased ownership as a positive signal of alignment with shareholder interests and confidence in the company's future, particularly as it's a pre-planned transaction.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director exercised stock options and increased their beneficial ownership under a pre-planned 10b5-1 program. While this indicates confidence, it is a standard compensation event and does not provide new fundamental information to warrant a change in investment recommendation. Investors should 'hold' and continue to monitor broader company performance and market conditions.

Keywords

Astrana Health, ASTH, Form 4, Insider Transaction, Stock Option Exercise, Director Ownership, Mitchell W. Kitayama, 10b5-1 Plan, Beneficial Ownership